TY - BOOK
T1 - Heterocyclic Anticancer Agents
AU - Banik, Bimal Krishna
AU - Banerjee, Bubun
N1 - Publisher Copyright:
© 2022 Walter de Gruyter GmbH, Berlin/Boston. All rights reserved.
PY - 2022/6/21
Y1 - 2022/6/21
N2 - Cancer is an incredibly diverse and difficult disease to treat, and even after decades of research there is no definitive cure. Therefore, it is highly crucial to search for novel and new organic molecules with high potency, low toxicity, and low mutagenicity with selective anticancer properties that are able to overcome frequently developed resistance to available drugs. Heterocyclic anticancer agents are an important class of drugs for cancer therapies. This book explores different heterocycles and their use as anticancer therapies. Topics covered include different heterocyclic derivatives, the impact of heterocycles on anticancer agent development, and naturally occurring heterocycles. Explores heterocycles and their use as anticancer therapies. Contains chapters on various heterocyclic derrivatives, the impact of heterocycles on anticancer agent development, and naturally occuring heterocycles.
AB - Cancer is an incredibly diverse and difficult disease to treat, and even after decades of research there is no definitive cure. Therefore, it is highly crucial to search for novel and new organic molecules with high potency, low toxicity, and low mutagenicity with selective anticancer properties that are able to overcome frequently developed resistance to available drugs. Heterocyclic anticancer agents are an important class of drugs for cancer therapies. This book explores different heterocycles and their use as anticancer therapies. Topics covered include different heterocyclic derivatives, the impact of heterocycles on anticancer agent development, and naturally occurring heterocycles. Explores heterocycles and their use as anticancer therapies. Contains chapters on various heterocyclic derrivatives, the impact of heterocycles on anticancer agent development, and naturally occuring heterocycles.
UR - http://www.scopus.com/inward/record.url?scp=85136417881&partnerID=8YFLogxK
U2 - 10.1515/9783110735772
DO - 10.1515/9783110735772
M3 - Libro
AN - SCOPUS:85136417881
SN - 9783110739268
BT - Heterocyclic Anticancer Agents
PB - de Gruyter
ER -